3 recruiting, 2 completed. 5 Phase 2, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Recruiting 3, Completed 2 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Recruiting 2 |
Follow Acute Lymphoblastic Leukemia ALL: new trials by email Literature Review of Acute Lymphoblastic Leukemia ALL trials Research Report on Acute Lymphoblastic Leukemia ALL
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol Blinatumomab, Reinduction-2 omission, Chemo-light Maintenance 2 - Acute Lymphoblastic Leukemia ALL, Childhood Leukemia, Acute Lymphoblastic | Phase 2 / Phase 3 | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 3000 | 2025-03-03 | 2025-08-26 |
| Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol Blinatumomab (Group A), Venetoclax (nonRand Group), Blinatumomab (Group B) - Acute Lymphoblastic Leukemia ALL, Childhood Leukemia, Acute Lymphoblastic | Phase 2 / Phase 3 | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 1800 | 2025-01-03 | 2026-07-23 |
| A Study to Evaluate the Tolerability, Safety, and Efficacy of an Anti-CD19 CAR-T Product in Patients With B-cell Lymphoproliferative Disorders Hem101 - Non-Hodgkin Lymphoma, B-cell, Acute Lymphoblastic Leukemia ALL | Phase 1 / Phase 2 | Completed | National Research Center for Hematology, Russia | 58 | 2024-11-26 | 2026-02-09 |
| Autologous Hematopoietic Stem Cell Transplantation Combined With CD19-CART Treatment of Adult High-risk Acute Lymphoblastic Leukemia Autologous hematopoietic stem cell transplantation combined with CD19-CART - Acute Lymphoblastic Leukemia ALL | Phase 2 | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 20 | 2024-06-25 | 2024-09-23 |
| Safety and Preliminary Efficacy of Donor-derived Anti-leukemia Cytotoxic T Lymphocytes for the Prevention of Leukemia Relapse in Children Given Haploidentical Hematopoietic Stem Cell Transplantation HSCT donor leukemia-specific cytotoxic T-cells - Acute Lymphoblastic Leukemia ALL, Acute Myeloid Leukemia (AML) | Phase 1 / Phase 2 | Completed | Fondazione IRCCS Policlinico San Matteo di Pavia | 15 | 2021-02-13 | 2025-03-07 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (5) · Burkitt Lymphoma (2) · Leukemia, Myeloid, Acute (1) · Lymphoma, B-Cell (1) · Lymphoma, Non-Hodgkin (1)
Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Immune System Diseases (5) · Immunoproliferative Disorders (5) · Leukemia (5) · Leukemia, Lymphoid (5) · Lymphatic Diseases (5) · Lymphoproliferative Disorders (5) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Lymphoma (3) · DNA Virus Infections (2) · Epstein-Barr Virus Infections (2) · Herpesviridae Infections (2) · Infections (2)
Dexamethasone (2) · Methotrexate (2) · Vincristine (2) · blinatumomab (2) · Asparaginase (1) · Cyclophosphamide (1) · Cytarabine (1) · Daunorubicin (1) · Prednisone (1) · venetoclax (1)
Institute of Hematology & Blood Diseases Hospital, China (3) · Fondazione IRCCS Policlinico San Matteo di Pavia (1) · National Research Center for Hematology, Russia (1)
China (3) · Hong Kong (2) · Italy (1) · Russia (1)
Xiaofan Zhu, MD (2)